Asthma and lower airway disease
Influence of childhood growth on asthma and lung function in adolescence

https://doi.org/10.1016/j.jaci.2014.10.046Get rights and content
Under a Creative Commons license
open access

Background

Low birth weight and rapid infant growth in early infancy are associated with increased risk of childhood asthma, but little is known about the role of postinfancy growth in asthmatic children.

Objectives

We sought to examine the associations of children's growth patterns with asthma, bronchial responsiveness, and lung function until adolescence.

Methods

Individual growth trajectories from birth until 10 years of age were estimated by using linear spline multilevel models for 9723 children participating in a population-based prospective cohort study. Current asthma at 8, 14, and 17 years of age was based on questionnaires. Lung function and bronchial responsiveness or reversibility were measured during clinic visits at 8 and 15 years of age.

Results

Rapid weight growth between 0 and 3 months of age was most consistently associated with increased risks of current asthma at the ages of 8 and 17 years, bronchial responsiveness at age 8 years, and bronchial reversibility at age 15 years. Rapid weight growth was associated with lung function values, with the strongest associations for weight gain between 3 and 7 years of age and higher forced vital capacity (FVC) and FEV1 values at age 15 years (0.12 [95% CI, 0.08 to 0.17] and 0.11 [95% CI, 0.07 to 0.15], z score per SD, respectively) and weight growth between 0 and 3 months of age and lower FEV1/FVC ratios at age 8 and 15 years (−0.13 [95% CI, −0.16 to −0.10] and −0.04 [95% CI, −0.07 to −0.01], z score per SD, respectively). Rapid length growth was associated with lower FVC and FVC1 values at age 15 years.

Conclusion

Faster weight growth in early childhood is associated with asthma and bronchial hyperresponsiveness, and faster weight growth across childhood is associated with higher FVC and FEV1 values.

Key words

ALSPAC
asthma
cohort study
growth
lung function

Abbreviations used

ALSPAC
Avon Longitudinal Study of Parents and Children
FEF25-75
Forced expiratory flow between 25% and 75%
FVC
Forced vital capacity
OR
Odds ratio

Cited by (0)

The Avon Longitudinal Study of Parents and Children (ALSPAC) receives core funding (102215/2/13/2) from the UK Medical Research Council, the Wellcome Trust (grant reference 092731) and the University of Bristol. The lung function measures were supported by a grant from the UK Medical Research council (G0401540). A.M.M.S.-V. is the recipient of a European Respiratory Society Fellowship (STRTF 93-2012) and received a grant from the Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences (TMF2012/228). L.D.H. and R.G. are funded by UK Medical Research Council fellowships (G1002375 and G0401540). L.D.H. and K.T. work in a unit that receives funding from the UK Medical Research Council (MC_UU_12013/5) and the University of Bristol. L.D. received funding from a European Respiratory Society/Marie Curie Joint Research Fellowship (no. MC 1226-2009, grant agreement RESPIRE, PCOFUND-GA-2008-229571) and the Lung Foundation Netherlands (no 3.2.12.089; 2012).

Disclosure of potential conflict of interest: A. Sonnenschein-van der Voort has received research support from the European Respiratory Society Fellowship (STRTF 93-2012) and the Ter Meulen Fund, Royal Netherlands Academy of Arts and Sciences (TMF2012/228). L. D. Howe has received research support from the Medical Research Council (UK; MC_UU_12013/5) and Nestlé. L. Duijts has received research support from the European Respiratory Society/Marie Curie Joint Research Fellowship (no. MC 1226-2009, grant agreement RESPIRE, PCOFUND-GA-2008-229571) and Lung Foundation Netherlands (no. 3.2.12.089; 2012). J. A. C. Sterne has received research support from UK MRC. K. Tilling presented linear spline methods at an International Research Workshop on Analysis of Child Growth Trajectories, and travel expenses and an honorarium were paid; the workshop was supported by the Centre for Advanced Studies LMU, the German Research Council DFG, and unrestricted educational grants from Abbott Nutrition and the International Life Sciences Institute. A. J. Henderson has received research support from the Medical Research Council and the Wellcome Trust. R. Granell declares that she has no relevant conflicts of interest.